Supreme Pharmacist System

"Papa..."

"Papa papa..."

The scholars at the scene gave Zhou Wenbao the warmest applause, which was a far cry from the sparse applause at the beginning.

Zhou Wen thanked the audience several times and nodded to the audience, all of which received warm applause again.

After three times, the applause finally slowly disappeared.

Zhou Wen said slowly: "As we all know, unlike healthy cells, cancer cells are constantly dividing and need to synthesize new DNA and RNA to support the production of new cells.

But after our relentless research, we found that early-stage lung cancer has an unexpected vulnerability, especially dependent on the pyrimidine biosynthesis pathway, and an agent we call melanase can effectively resist it in cell lines and mouse models. ..."

Following Zhou Wen's speech, the faces of thousands of lung cancer experts and scholars in the audience gradually showed surprise.

"And with more in-depth research, we have made a breakthrough in the treatment of early lung cancer!"

After a pause, as all the experts held their breaths, Zhou Wen said: "Using this weakness, we successfully resisted the invasion of early-stage lung cancer and further effectively killed it."

Following Zhou Wen's speech, the big screen behind him lit up, and a graph of experimental data appeared on it.

Zhou Wen lowered his head and slid the iPad on the podium, and the data graph on the big screen also moved left and right.

"Code-named DST-104, this is the first simulation experiment three months ago, mainly targeting the more common mutant genes EGFR, ALK, cMET, ROS1, HER2, KRAS, etc... This is the second simulation experiment two months ago Animal experiment……"

Following Zhou Wen's explanation, the scene was silent at first, but gradually boiled over.

Countless experts and scholars began to discuss loudly.

"Didn't Dr. Aung Naing say that the effect of anti-PD-1 monoclonal antibody treatment alone is not good? Why is his reaction just the opposite?"

"Hey, look, the gene sequence of this dihydroorotate dehydrogenase has changed."

"Why does this lanthanum enzyme react in such a strange way..."

The experimental data announced by Zhou Wen was like throwing a boulder under the calm lake, instantly setting off huge waves.

On-site lung cancer experts are getting louder and louder.

And those medical professionals who don't have a thorough understanding of lung cancer, representatives of pharmaceutical companies, and patients with lung cancer who listen to them, although they can't understand the complicated theoretical knowledge and target maps, they understand Zhou Wen's words-early lung cancer can be completely cured .

"Is what he said true? Can early stage lung cancer be completely cured?"

"Impossible, there was no news at all before."

"This person is the winner of the Gairdner Award, so he shouldn't be talking nonsense..."

Wu Yilong, who was sitting in the middle, was also extremely surprised at this time.

Before, he was guessing how Zhou Wen, a person who studies biological viruses, would appear at the lung cancer conference. He didn't expect that the other party really made a breakthrough in the field of lung cancer research.

"teacher,

How true is this data? " asked the assistant sitting next to Wu Yilong.

Wu Yilong looked at the experimental data on the big screen without blinking, and said in a solemn tone: "We can't be sure yet, we need to do experiments to know."

After a pause for half a second, Wu Yilong followed up: "But this man is a medical prodigy with brilliant achievements in oncology. It is very likely that he is real."

The assistant looked at the data on the big screen with a look of shock on his face.

His teacher has been studying lung tumors for 20 years. Although he has achieved remarkable results, most of them are based on foreign research results.

Like Zhou Wen, he can directly attack early-stage lung cancer, especially small cell lung cancer, which accounts for 15% of the total lung cancer. Due to its high degree of malignancy, treatment options are limited. So far, there is no approved targeted drug in the world.

Zhou Wen directly announced that he could be cured, which was simply too scary.

And since it has a curative effect on early-stage lung cancer, it means that it must also have a quite obvious effect on mid-stage and late-stage lung cancer.

How is this not shocking?

The hum of the scene grew louder.

Especially those tumor and lung tumor specialists were full of question marks at this time, but Zhou Wen had already walked off the podium.

The host Ronald, after whispering to the people around him, said: "Ahem... First of all, thank you Professor Zhou Wen for your wonderful speech. Just now, Dr. Taylor and Professor Nicholas said that they would leave ten minutes for everyone. One minute for questions, Professor Zhou, take a look..."

Zhou Wen, who had just walked to his seat, said with a smile, "Okay..."

...

The news that early stage lung cancer has been conquered, without any surprise, quickly made it to the mainstream media in Singapore, China, France, Italy, Germany, Russia and other major countries in the world.

Soon the United States, Britain, South Korea, Australia, New Zealand and other countries also carried out reports.

In private, countless lung cancer research institutes and pharmaceutical companies in Western countries were surprised and astonished after hearing the news.

In terms of tumor treatment, research institutes in Western countries have always been at the forefront of the world. Every year, they rely on the authorization of pharmaceutical agents to snatch tens of billions of dollars in profits from China.

But unexpectedly, this time Chinese pharmaceutical companies were the first to produce research results.

As for those giant pharmaceutical companies in Europe and America, they were a little stunned at first, but when they saw Zhou Wen's name, the astonishment on their faces quickly returned to normal.

These pharmaceutical giants have a more thorough understanding of Zhou Wen.

In addition to increasing the speed of new drug development, they also launched a more in-depth commercial investigation of Zhou Wen and Huanyu Biopharmaceuticals.

On October 13, Huanyu Biology held its first press conference at the Jiangzhou Taihu International Conference Center.

Mainly answering questions from reporters on specific HIV drugs, new allergy-suppressing drugs, and new lung cancer drugs.

More than 1,600 journalists from more than 70 countries around the world attended the press conference.

For the first time, Huanyu Biology came to the foreground from behind the scenes.

The press conference was broadcast live.

Luo Zongwei, Vice President and Director of Marketing Operations Department of Huanyu Bio, answered more than 60 questions raised by reporters.

Many people learned about Huanyu's scientific research strength for the first time.

For example, in its laboratories, there are astonishingly more than 400 researchers with doctoral degrees alone, and more than 1,500 masters and undergraduates who graduated from key universities.

"Our scientific research investment is also very huge. In the first half of 2020, the salary expenditure of personnel alone reached 750 million, and the experimental funds exceeded 2 billion."

"Under such a costly investment, the output results are naturally very gratifying."

"For example, the biological ointments just launched have very good curative effects on various skin diseases. For example, ichthyosis, folliculitis, scleroderma, and psoriasis, etc., have been verified."

"Moreover……"

Taking advantage of the opportunity of the press conference, Luo Zongwei also lost no time in promoting the company's products...

Spotlights flickered at the conference site, and major pharmaceutical companies at home and abroad basically paid attention to the conference.

Overseas Pfizer, Novartis, Roche, Moke, Sanofi, Gunsound, Gilead Sciences, GlaxoSmithKline, AbbVie, Amgen, AstraZeneca, Allergan, etc.

Domestic companies like Hengrui, Marui, Yaoming Apptech, Ahli Health, Yunan Medicine, Hengda Health, Sinopharm Holdings, Zhifei Bio, Yaoming Bio, CSPC and so on.

The previous scientific research results have made these company executives and shareholders envious and jealous.

And their talent pool makes many domestic companies feel inferior.

Of course they know that a Ph.D. is good, and students who graduate from key universities are smart, so they can't afford to hire them.

A doctoral student should be paid at least two to three hundred thousand a year, right?

How much is ten?

How much is one hundred?

In addition, how much salary do masters and undergraduates in key universities pay each year?

These are all money!

There are also experimental consumables and so on.

Such a huge investment in scientific research is comparable to those large domestic pharmaceutical companies.

However, when Luo Zongwei talked about the output of scientific research, many people were dismissive and contemptuous.

This is pure nonsense.

They recognize that pharmaceuticals are high-input and high-output industries.

However, there is a problem here. Pharmaceuticals do not pay off for investment.

If this is the case, domestic capital would have already flocked to it, so how could it be possible for them all to engage in real estate?

...

Huanyu Biotech made its debut, and its strength surprised many domestic pharmaceutical companies.

Villa No. 108, Jiangnan Garden, basketball room.

Zhou Wen stood outside the three-point line and patted the basketball lightly, watching the live broadcast of the press conference on the wall.

"Pong-pong-pong--"

When there was warm applause at the press conference, he smiled and threw it away. The basketball drew a beautiful arc and fell into the basket.

The basketball didn't roll out of the line or bounce to other places as expected, but bounced a few times on the ground, and just happened to fall into Zhou Wen's hands.

After Zhou Wen took a few shots of "Pang Bang Bang", he threw it into the basket again, and then bounced into his arms again as if he had eyes.

Then he leaned over slightly, like the All-Star game on TV, after doing a few extremely flamboyant fancy dribbles, he rushed forward, raising his body by more than three meters, and most of his body had already passed the basket.

After the body fell a little, he held the basketball in both hands and poured it into the basket with a "bang" sound!

The chassis of the mobile basketball hoop couldn't bear such a large force, and after shaking a few times, it fell to the side.

Zhou Wen had quick eyes and quick hands. After running two steps quickly, he supported the fallen basketball post with one hand and straightened it.

"Rubbish!"

Zhou Wen then threw the basketball into the basketball hoop by the wall, turned around and walked towards the door.

In front of the house is a small lotus pond, in which some precious goldfish are raised, and a little citta cat is squatting by the side of the lotus pond, its head keeps turning as the goldfish swims, as if thinking about how to do it. Just come up for a taste?

Zhou Wen walked over, and the little raccoon cat glanced at him, then let out a "meow", licked its mouth with its pink barbed tongue, and turned its head to look at the goldfish in the lotus pond "meow meow", as if saying: Shovel shit Yes, quickly grab one for me to eat.

Zhou Wen giggled, bent down to pick it up, patted its head and said with a smile, "You toad cat still wants to eat goldfish meat, he is worth much more than you."

"Aim~" The raccoon cat struggled for a while, but didn't break free, so it rubbed its head against Zhou Wen's neck vigorously.

"It's useless to act like a baby, go eat your cat food!"

Zhou Wen smiled and patted its head for a while, then put it on the ground.

The raccoon cat rubbed against his leg again, then walked to the side of the lotus pond with catwalks, looking down at the goldfish inside. It seems that he will not give up.

Zhou Wen smiled, ignored it, and walked along the path in front of the house to the big garden in the front yard.

The 11 o'clock sun shone on my face, which was a bit harsh.

At this moment, footsteps came from behind, and sister Qiu, the nanny, came over with a phone number.

Zhou Wen turned his head and asked, "Who is it?"

The nanny Qiu looked at the phone screen and said, "It shows sister-in-law."

"Ah? Oh..." Zhou Wen was taken aback for a moment before realizing that it was Chen Zhiyuan.

Take over and chat a few words.

It's okay, I just invited him to a birthday party at night.

"I just came back from Singapore yesterday, I'm a little tired, you go."

Chen Zhiyuan didn't force it, and said: "That's fine! By the way, I asked Mr. Tang if the house in Jiangnan Garden is ready, and she asked me to ask you myself."

Few people around Zhou Wen knew about buying a house, only Tang Xiaoli and Chen Zhiyuan, both of whom were very strict.

Zhou Wen: "I bought it, come and have a look when I have time, the place is huge."

Chen Zhiyuan: "How big is the area?"

Zhou Wen: "6500㎡."

Chen Zhiyuan: "..."

After hanging up the phone, he smiled and suddenly thought that the task had not been submitted yet.

Going to Singapore this time is also a series of tasks.

Originally, he didn't plan to announce the results of lung cancer research so early, at least he had to write a few SCI papers, but when the system came up with a task, he went along with it.

The task was submitted after turning on the system.

【Ding! mission completed. Congratulations, you have obtained 10,000 subject experience points and 5,000 points. 】

【Ding! mission completed. Congratulations, you have gained 20,000 subject experience points and 10,000 points. 】

Then he looked at the personal attribute column.

Host: [Zhou Wen]

Occupation: [Senior Pharmacist; 11580/100000]

Eye of True Sight: [LV3; 1079/50000]

Main subjects:

Pharmacology: [LV6; 0/200000]

Pathology: [LV6; 0/200000]

Biological Immunology: [LV7; 0/1000000]

Biochemistry: [LV6; 0/200000]

System Anatomy: [LV5; 0/100000]

Linguistics: [(English) (German) (Latin) (Japanese) (Wu) (Cantonese) (Russian) (Korean)]

Branch disciplines:

Botany; [LV6; 0/200000]

Zoology: [LV3; 0/20000]

Psychology: [LV4; 0/50000]

Subject experience: 【175053】

Points: 【313690】

The first is the pharmacist level.

It took a year of hard work to advance to the next level. I thought it would be even more difficult in the future.

I didn't expect to make a mid-level gene enhancer, but the upgrade was very fast. According to this speed, it would take about a year to upgrade to a master-level pharmacist.

But the premise is that the experience value added by making an intermediate pharmacist remains unchanged.

The second is the eye of truth.

During this time, the Eye of True Sight has been upgraded from LV2 to LV3.

As expected, the nucleus is now visible.

Compared with atoms, the atomic nucleus is equivalent to the gap between an egg and a house.

In addition, the subject of biological immunology has been upgraded, and he has a deeper understanding of genes and life.

This understanding could help him explore the nature of life and unravel the mysteries of genes.

After looking at it for a while, he opened the inventory and started to unpack the box...

The genius remembers the address of this site in one second:. Mobile version reading URL: